GeoVax Labs is a biotechnology business based in the US. GeoVax Labs shares (GOVX) are listed on the NASDAQ and all prices are listed in US Dollars. GeoVax Labs employs 14 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy GeoVax Labs stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – GOVX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 in stock when you fund a new account within 30 days
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
GeoVax Labs stock price (NASDAQ: GOVX)Use our graph to track the performance of GOVX stocks over time.
GeoVax Labs shares at a glance
|Latest market close||$0.52|
|52-week range||$0.51 - $1.39|
|50-day moving average||$0.57|
|200-day moving average||$0.66|
|Wall St. target price||$6.00|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.74|
Buy GeoVax Labs stock from these online trading platformsCompare special offers, low fees and a wide range of investment options among top trading platforms.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy GeoVax Labs stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
GeoVax Labs price performance over time
|1 week (2023-09-18)||-4.04%|
|1 month (2023-08-25)||-7.55%|
|3 months (2023-06-23)||-12.98%|
|6 months (2023-03-24)||-24.97%|
|1 year (2022-09-23)||-54.98%|
|2 years (2021-09-24)||-88.02%|
|3 years (2020-09-25)||2.94|
|5 years (2018-09-25)||480000|
GeoVax Labs financials
|Gross profit TTM||$81,526|
|Return on assets TTM||-45.44%|
|Return on equity TTM||-85.79%|
|Market Capitalization||$14.3 million|
TTM: trailing 12 months
GeoVax Labs share dividends
We're not expecting GeoVax Labs to pay a dividend over the next 12 months.
You may also wish to consider:
- Gilead Sciences (GILD.US) (3.96% forward annual dividend yield)
Have GeoVax Labs's shares ever split?
GeoVax Labs's shares were split on a 1:20 basis on 25 September 2020. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your GeoVax Labs shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for GeoVax Labs shares which in turn could have impacted GeoVax Labs's share price.
GeoVax Labs share price volatility
Over the last 12 months, GeoVax Labs's shares have ranged in value from as little as $0.51 up to $1.39. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while GeoVax Labs's is 2.9353. This would suggest that GeoVax Labs's shares are significantly more volatile than the average for this exchange and represent a higher risk.
To put GeoVax Labs's beta into context you can compare it against those of similar companies.
GeoVax Labs overview
GeoVax Labs, Inc. , a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.
GeoVax Labs in the news
GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference
GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients
GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference
Frequently asked questionsWhat percentage of GeoVax Labs is owned by insiders or institutions?
Currently 1.239% of GeoVax Labs shares are held by insiders and 6.076% by institutions. How many people work for GeoVax Labs?
Latest data suggests 14 work at GeoVax Labs. When does the fiscal year end for GeoVax Labs?
GeoVax Labs's fiscal year ends in December. Where is GeoVax Labs based?
GeoVax Labs's address is: 1900 Lake Park Drive, Smyrna, GA, United States, 30080 What is GeoVax Labs's ISIN number?
GeoVax Labs's international securities identification number is: US3736785078 What is GeoVax Labs's CUSIP number?
GeoVax Labs's Committee on Uniform Securities Identification Procedures number is: 373678408
More guides on Finder
How to buy Discord stock when it goes public
Everything we know about the Discord IPO, plus information on how to buy in.
Today’s trending Reddit stocks
We’ve pulled a list together of the meme stocks being mentioned most on Reddit in the past 24 hours.
How to buy Tottenham Acquisition I stock
Steps to owning and managing TOTA, with 24-hour and historical pricing before you buy.
How to buy TotalEnergies stock
Steps to owning and managing TOT, with 24-hour and historical pricing before you buy.
How to buy Thunder Bridge Acquisition stock
Steps to owning and managing THBR, with 24-hour and historical pricing before you buy.
How to buy Switchback Energy Acquisition Corporation stock
Steps to owning and managing SBE, with 24-hour and historical pricing before you buy.
How to buy Telefonica SA ADR stock
Steps to owning and managing TEF, with 24-hour and historical pricing before you buy.
How to buy Faraday Future stock
Steps to owning and managing PSACU, with 24-hour and historical pricing before you buy.
How to buy Phoenix Tree stock
Steps to owning and managing DNK, with 24-hour and historical pricing before you buy.
How to buy Innate Pharma stock
Steps to owning and managing IPHA, with 24-hour and historical pricing before you buy.
Ask an Expert